Skip to main content
TipRanks
Go Ultimate75% OFF

Drugs Made In America Acquisition Corp. (DMAA) Income Statement

2 Followers

Drugs Made In America Acquisition Corp. Income Statement

Last quarter (Q3 2026), Drugs Made In America Acquisition Corp.'s total revenue was $0.00. In Q3, Drugs Made In America Acquisition Corp.'s net income was $1.24M. See Drugs Made In America Acquisition Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24
$ 0.00$ 0.00
$ 0.00$ 0.00
$ 2.82M―
Depreciation and Amortization$ 0.00$ 479.73K
$ -2.82M$ 479.25K
$ -2.82M$ -479.00
$ 8.76M$ 0.00
$ 5.94M$ -479.00
$ 5.94M$ -479.00
Per Share Metrics
Basic EPS$ 0.19$ -0.06
Diluted EPS$ 0.19$ -0.06
Weighted Average Shares Outstanding21.01M8.57M
Weighted Average Shares Outstanding (Diluted)21.01M8.57M

Currency in USD

Drugs Made In America Acquisition Corp. Earnings and Revenue History

-4M04M8M0 %0.4 %0.8 %1.2 %EarningsProfit Margin20242025RevenueEarningsProfit Margin